.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Cerilliant
Argus Health
Covington
Julphar
Healthtrust
Citi
Mallinckrodt
Dow
AstraZeneca

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091083

« Back to Dashboard
NDA 091083 describes NABUMETONE, which is a drug marketed by Chartwell Molecules, Mylan Pharms Inc, Dr Reddys Labs Ltd, Apotex Inc, Lupin Ltd, Invagen Pharms, Copley Pharm, Sandoz, Watson Labs, Impax Labs Inc, and Oxford Pharms, and is included in twelve NDAs. It is available from forty suppliers. Additional details are available on the NABUMETONE profile page.

The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nabumetone profile page.

Summary for NDA: 091083

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 091083

Suppliers and Packaging for NDA: 091083

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NABUMETONE
nabumetone
TABLET;ORAL 091083 ANDA Actavis Pharma, Inc. 0591-3670 0591-3670-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-01)
NABUMETONE
nabumetone
TABLET;ORAL 091083 ANDA Actavis Pharma, Inc. 0591-3670 0591-3670-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3670-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jun 13, 2011TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength750MG
Approval Date:Jun 13, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Covington
Citi
Chubb
Mallinckrodt
US Army
Boehringer Ingelheim
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot